Emerin regulation of myogenic differentiation: implications for muscle disease
Emerin regulation of myogenic differentiation: implications for muscle disease
批准号:
10579536
负责人:
JAMES Michael HOLASKA
金额:
$47.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-04-01 至 2026-06-30
关键词:
AcetylationBindingChromatinContractureDataDifferentiated GeneDiseaseEmery-Dreifuss Muscular DystrophyEnsureFailureFunctional disorderGenesGenetic TranscriptionGenomeGenomicsHDAC3 geneHereditary DiseaseHistonesHomeostasisImpairmentInjuryKnowledgeMediatingModelingMolecularMuscle satellite cellMutationMyopathyNatural regenerationNeuromuscular DiseasesNuclear EnvelopeNull LymphocytesPathogenesisPathologyPost-Translational Protein ProcessingRegulationRepressionRoleSkeletal MuscleTendon structureTestingX-linked Emery-Dreifuss muscular dystrophyemerinenv Gene Productsheart rhythmhistone acetyltransferaseinhibitorinsightmuscle regenerationmutantprogenitorprogramsskeletal muscle wastingspatiotemporalstem cell differentiationstem cellstherapy developmenttissue repairtranscriptional reprogrammingtranscriptome sequencing
中文摘要
x连锁埃默里-德莱富斯肌营养不良症(EDMD1)是一种以进行性为特征的遗传性疾病
英文摘要
X-linked Emery-Dreifuss muscular dystrophy (EDMD1) is an inherited disorder characterized by progressive
skeletal muscle wasting, irregular heart rhythms, and major tendon contractures. EDMD1 is caused by
mutations in emerin, an inner nuclear envelope protein, but the molecular mechanisms for the pathogenesis
remains unknown. We do know that the skeletal muscle pathogenesis in EDMD1 is related to impaired muscle
regeneration due to compromised muscle stem cell differentiation. During differentiation, the genome in muscle
stem cells is dynamically reorganized to coordinate the temporal expression of the differentiation transcriptional
program. Our previous data showed the functional interaction between emerin and histone deacetylase 3
(HDAC3) contributes to regulating this genomic reorganization. Our working hypothesis is that the dynamic
interaction between emerin and HDAC3 regulates the genomic reorganization necessary for differentiation. We
further predict abrogation of this interaction by EDMD1-causing emerin mutations disrupt this genomic
reorganization to block transcriptional reprogramming. To test this hypothesis, we will: Aim 1. Determine how
emerin binding to HDAC3 organizes repressed myogenic loci at the nuclear envelope (NE); Aim 2. Evaluate
the dynamic organization of myogenic loci at the NE during differentiation and its dysfunction in EDMD1; and
Aim 3. Test if shifting H4K5 acetylation dynamics by treatment with histone acetyltransferase (HAT) inhibitors
or HDAC3 activators rescues EDMD1 differentiation. Completion of these studies will provide mechanistic
insight into the impaired muscle regeneration underlying the skeletal muscle pathogenesis of EDMD1. These
studies will also significantly impact other neuromuscular diseases because muscle regeneration is important
in many of these diseases. Completion of these studies will also have a broader impact because repairing
tissue damage throughout the body uses resident stem cells that require the coordinated temporal expression
of differentiation genes, which is dictated by dynamic genomic reorganization.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/cphy.c150039
发表时间:
2016-09-15
期刊:
Comprehensive Physiology
影响因子:
5.8
作者:
[Holaska JM]
通讯作者:
Holaska JM
DOI:
10.1242/dmm.028787
发表时间:
2017-04-01
期刊:
Disease models & mechanisms
影响因子:
4.3
作者:
[Collins CM, Ellis JA, Holaska JM]
通讯作者:
Holaska JM
DOI:
10.3390/ijms21175944
发表时间:
2020-08-19
期刊:
International journal of molecular sciences
影响因子:
5.6
作者:
[Gómez-Monsivais WL, Monterrubio-Ledezma F, Huerta-Cantillo J, Mondragon-Gonzalez R, Alamillo-Iniesta A, García-Aguirre I, Azuara-Medina PM, Arguello-García R, Rivera-Monroy JE, Holaska JM, Hernández-Méndez JME, Garrido E, Magaña JJ, Winder SJ, Brancaccio A, Martínez-Vieyra I, Navarro-Garcia F, Cisneros B]
通讯作者:
Cisneros B
DOI:
10.1158/1541-7786.mcr-20-0413
发表时间:
2021-07
期刊:
Molecular cancer research : MCR
影响因子:
--
作者:
[Liddane AG, McNamara CA, Campbell MC, Mercier I, Holaska JM]
通讯作者:
Holaska JM
DOI:
10.3390/ijms222011289
发表时间:
2021-10-19
期刊:
International journal of molecular sciences
影响因子:
5.6
作者:
[Liddane AG, Holaska JM]
通讯作者:
Holaska JM
Emerin regulation of molecular pathways: implications for muscle disease
-
批准号:9548053
-
项目类别:
-
资助金额:$21.02万
-
财政年份:2017
-
负责人:JAMES Michael HOLASKA
-
依托单位:
Emerin regulation of molecular pathways: implications for muscle disease
-
批准号:9098125
-
项目类别:
-
资助金额:$24.14万
-
财政年份:2016
-
负责人:JAMES Michael HOLASKA
-
依托单位:
Emerin functions in transcriptional regulation
-
批准号:6584099
-
项目类别:
-
资助金额:$4.16万
-
财政年份:2003
-
负责人:JAMES Michael HOLASKA
-
依托单位:
Emerin functions in transcriptional regulation
-
批准号:6742494
-
项目类别:
-
资助金额:$1.54万
-
财政年份:2003
-
负责人:JAMES Michael HOLASKA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: